OMERS ADMINISTRATION Corp acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, HoldingsChannel.com reports. The fund acquired 547,569 shares of the company’s stock, valued at approximately $70,363,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in shares of Merck KGaA during the second quarter worth about $942,087,000. Bank of Nova Scotia acquired a new stake in Merck KGaA in the second quarter valued at about $281,696,000. Danske Bank A S acquired a new stake in Merck KGaA in the second quarter valued at about $276,535,000. Korea Investment CORP purchased a new stake in Merck KGaA in the 2nd quarter valued at approximately $239,191,000. Finally, Great Lakes Advisors LLC acquired a new position in Merck KGaA during the 2nd quarter worth approximately $183,444,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Performance
Shares of MKGAF stock opened at $163.21 on Monday. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The stock has a 50 day simple moving average of $162.62 and a 200-day simple moving average of $148.44. The company has a market cap of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
